Reavidence Inc Information

Changing the way Real World Evidence is generated - one analysis at a time! Reavidence developed robust solutions encompassing all aspects of Real World Evidence (RWE) generation. These solutions simplify, speed-up, and strengthen your RWE. RapidAnalyzer™ is a platform that uses customized technologies for the healthcare industry to accomplish a full RWE study in few weeks Vs. the typical timescale of 3-6 months with currently available tools. RapidAnalyzer ™ has been developed by experienced professionals in the field of RWE with extensive knowledge of database analyses – claims data, hospital data, patient registries, and clinical trials. Our team of professionals collectively have published over 300 peer-reviewed publications and accumulated 1000s of hours of experience in RWE generation in diverse therapeutic areas – oncology, rare diseases, neurosciences, neurology, GI, CVME – to name a few. Our team has supported RWE on the global scale for Big Pharma and also in Bio-Tech. RapidAnalyzer ™ engineering team comprises of personnel with experience in standards such as OMOP and ICD10 and technologies such as Hadoop, R, Spark, Python and Impala among others. We are proud to claim RapidAnalyzer ™ being the first of its kind to incorporate unique features of Machine Learning, Content Management to store and report studies, flexible visualization tools, simultaneous studies of multiple datasets using single instructions and last but not the least, being data source agnostic. RapidAnalyzer ™ has been designed to be cloud-ready, In-premises computing ready or a Hybrid version of in-premises/Cloud implementation. Our standard offering is to support In-Premises implementation while providing with the user to finally determine their preference. Please feel free to review the architecture to further gain insight into the platform.